Nonalcoholic fatty liver disease (NAFLD) is a dynamic chronic liver disease that develops in
close association with metabolic irregularities. Between 2016 and 2019, the global …

The existing term non-alcoholic fatty liver disease (NAFLD) has raised substantial concerns
due to its inherent disadvantages of using exclusionary diagnostic criteria and the …

Background The reference standard for detecting non-alcoholic steatohepatitis (NASH) and
staging fibrosis—liver biopsy—is invasive and resource intensive. Non-invasive biomarkers …

Non-alcoholic fatty liver disease (NAFLD) is common, affecting approximately 25% of the
general population. The evidence base for the investigation and management of NAFLD is …

Conclusions: This consensus-driven multidisciplinary fatty liver disease action agenda
developed by care providers, clinical researchers, and public health and policy experts …

Abstract Non-Alcoholic Fatty Liver Disease (NAFLD) refers to the accumulation of lipid laden
vacuoles in hepatocytes, occurring in the context of visceral adiposity, insulin resistance and …

Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease associated with the
pathological accumulation of lipids inside hepatocytes. Untreated NAFL can progress to non …

Abstract Background and Aims The evaluation of the natural history of NASH has been
limited. Currently, liver biopsy remains the gold standard in the assessment of NASH …

Liver disease prevalence, severity, outcomes and hepatic risk factors (for example,
unhealthy diet) are heavily affected by socioeconomic status and food insecurity. Metabolic …

Ubiquitination and deubiquitination are reversible processes that modify the characteristics
of target proteins, including stability, intracellular localization, and enzymatic activity …